Abstract
No AccessJournal of UrologyNew Technology and Techniques1 Jun 2022Editorial CommentThis article comments on the following:Antegrade Instillation of UGN-101 (Mitomycin for Pyelocalyceal Solution) for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical Experienceis a letter which has replyReply by Authors Craig V. Labbate, Mehrad Adibi, and Surena F. Matin Craig V. LabbateCraig V. Labbate Department of Urology, MD Anderson Cancer Center, Houston, Texas More articles by this author , Mehrad AdibiMehrad Adibi Department of Urology, MD Anderson Cancer Center, Houston, Texas More articles by this author , and Surena F. MatinSurena F. Matin Department of Urology, MD Anderson Cancer Center, Houston, Texas More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002454.02AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, 207(6), pp. 1309–1310 Reference 1. : Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial. Lancet Oncol 2020; 21: 776. Google Scholar © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyFeb 7, 2022, 12:00:00 AMAntegrade Instillation of UGN-101 (Mitomycin for Pyelocalyceal Solution) for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical ExperienceJournal of UrologyMar 3, 2022, 12:00:00 AMReply by Authors Volume 207Issue 6June 2022Page: 1309-1310 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Craig V. Labbate Department of Urology, MD Anderson Cancer Center, Houston, Texas More articles by this author Mehrad Adibi Department of Urology, MD Anderson Cancer Center, Houston, Texas More articles by this author Surena F. Matin Department of Urology, MD Anderson Cancer Center, Houston, Texas More articles by this author Expand All Advertisement PDF DownloadLoading ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
